Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer ; volume:5 ; number:1 ; day:19 ; month:2 ; year:2024 ; pages:1-4 ; date:12.2024
Molecular biomedicine ; 5, Heft 1 (19.2.2024), 1-4, 12.2024
- Creator
-
Woodward, Alexis
Southard, Benjamin
Chakraborty, Sampurna
Bailey, Aaron O.
Faria, Gabriela N. F.
McKernan, Patrick
Razaq, Wajeeha
Harrison, Roger G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-023-00167-7
- URN
-
urn:nbn:de:101:1-2024032621515049411427
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Woodward, Alexis
- Southard, Benjamin
- Chakraborty, Sampurna
- Bailey, Aaron O.
- Faria, Gabriela N. F.
- McKernan, Patrick
- Razaq, Wajeeha
- Harrison, Roger G.
- SpringerLink (Online service)
Other Objects (12)
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Annexin A5 und wiederholte Fehlgeburten
Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
A Potential Antibody–Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer
Metastatic Triple-Negative Breast Cancer
Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Increased levels of circulating Annexin A5 in Familial Mediterranean fever
Annexin A5 reduces early plaque formation in ApoE -/- mice
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer
AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Annexin A5 und wiederholte Fehlgeburten
Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
A Potential Antibody–Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer
Metastatic Triple-Negative Breast Cancer
Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Increased levels of circulating Annexin A5 in Familial Mediterranean fever
Annexin A5 reduces early plaque formation in ApoE -/- mice
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer
AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Annexin A5 und wiederholte Fehlgeburten
Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
A Potential Antibody–Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer
Metastatic Triple-Negative Breast Cancer
Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Increased levels of circulating Annexin A5 in Familial Mediterranean fever
Annexin A5 reduces early plaque formation in ApoE -/- mice
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer